Article
Mismatch repair deficiency assessment by immunohistochemistry: for Lynch syndrome screening and beyond.
Future oncology (London, England) - 1 Nov 2018
Wong Hui-Li, Christie Michael, Gately Lucy, Tie Jeanne, Lee Belinda, Semira Christine, Lok Sheau Wen, Wong Rachel, Gibbs Peter
Abstract excerpt
While mismatch repair (MMR) deficiency has been studied extensively, the assessment of MMR status in colorectal and other cancers remains highly relevant, particularly in light of recent data demonstrating that MMR deficiency is a strong predictor for treatment benefit with immune checkpoint inhibitors across multiple tumor types. In colorectal cancer, there is a growing consensus in support of routine MMR...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
